It is possible that FABP4 concentration would be higher in patients with metabolic or cardiovascular diseases than in young healthy individuals [7, 8, 9, 10, 11, 12, 13, 14] Moreover, cancer patients would have a greater circulating FABP4 concentration [15]. This evidence concerns the gene FABP4 and cancer.